Head-to-head · WeighScore
MDExam vs Vitara RX
By GLP-1 ScorecardUpdated
Score comparison
Vitara RX has the higher recorded score — 86/100 to 55.6/100.
Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Sub-$100 semaglutide and $149 tirzepatide — both molecules, verified and nationwide.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | MDExam | Vitara RX |
|---|---|---|
| WeighScore | 55.6/100 | 86/100 |
| Grade | C | B |
| Site position | #485 | #11 |
| Semaglutide | Program advertised from $225/mo; confirm medication and dose | $99/mo |
| Tirzepatide | Specific current price unverified | $149/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #485 · C
Strengths
- Publishes a starting program price including medication and coaching
- Describes video visits, nurse access and ongoing treatment adjustments
What to consider
- Starting amount does not establish a specific tirzepatide or all-dose recurring price
- Cash-access marketing and insurance-dependent prescription costs describe different arrangements
- Cancel before the prescription is sent to the pharmacy; no refund after an eligible prescription is transmitted
Site position #11 · B
Strengths
- $99 sema / $149 tirz — bottom-quartile pricing
- Both molecules, all 50 states
- LegitScript-verified
What to consider
- Injection-only, no oral route
- Labs/monitoring not detailed
- Newer, thinner track record
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.